Therefore, we can suggest that LAPTM4B 2/2 genotype may combine more AP4 protein in LAPTM4B promoter region so that promote LAPTM4B function in HCC leading to a poor prognosis. This evidence concerns the gene LAPTM4B and hepatocellular carcinoma.